Simplex Trading
TARS icon

Simplex Trading’s Tarsus Pharmaceuticals TARS Stock Holding History

Simplex Trading’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.01K Buy
+100
New +$6.99K ﹤0.01% 7656
2025
Q4 		– Sell
-800
Closed -$47K – 10029
2025
Q3 		$47K Buy
800
+500
+167% +$24.6K ﹤0.01% 6527
2025
Q2 		$12K Sell
300
-1,100
-79% -$49.5K ﹤0.01% 7199
2025
Q1 		$71K Sell
1,400
-400
-22% -$19.8K ﹤0.01% 5431
2024
Q4 		$99K Sell
1,800
-22,900
-93% -$1.04M ﹤0.01% 5186
2024
Q3 		$812K Buy
24,700
+10,700
+76% +$301K ﹤0.01% 3115
2024
Q2 		$380K Buy
14,000
+8,600
+159% +$289K ﹤0.01% 3953
2024
Q1 		$196K Buy
5,400
+3,800
+238% +$112K ﹤0.01% 4886
2023
Q4 		$32K Buy
1,600
+100
+7% +$1.67K ﹤0.01% 6515
2023
Q3 		$26K Buy
+1,500
New +$26.5K ﹤0.01% 6397
2023
Q1 		– Sell
-11,500
Closed -$168K – 10115
2022
Q4 		$168K Hold
11,500
– – ﹤0.01% 4446
2022
Q3 		$196K Buy
11,500
+900
+8% +$14.3K ﹤0.01% 4637
2022
Q2 		$154K Buy
+10,600
New +$159K ﹤0.01% 4958

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's TARS Position: Q1 2026 in Review

Simplex Trading reduced its Tarsus Pharmaceuticals (TARS) stake by 18% in Q1 2026, selling an estimated $38.3K and leaving 2,465 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #4471.

Simplex Trading first reported a position in TARS in Q2 2023 and has held it in 6 quarters since. The position peaked at $587K in Q1 2024. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Simplex Trading held 2,465 shares of Tarsus Pharmaceuticals worth $173K as of Q1 2026.
  • Simplex Trading sold 548 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $38.3K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4471 holding.
  • Simplex Trading first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • Simplex Trading's Tarsus Pharmaceuticals position peaked at $587K in Q1 2024.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.